Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
June-2023 Volume 27 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
June-2023 Volume 27 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Reduced glutathione ameliorates acute kidney injury by inhibiting ferroptosis

  • Authors:
    • Leyu He
    • Yuan Shi
  • View Affiliations / Copyright

    Affiliations: Department of Nephrology, Jiaxing Second Hospital, Jiaxing, Zhejiang 314000, P.R. China
    Copyright: © He et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 123
    |
    Published online on: May 12, 2023
       https://doi.org/10.3892/mmr.2023.13011
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Reduced glutathione (RGSH) can participate in the redox process in the body and inhibit damage to important organs caused by free radicals. Due to its broad biological effects, in addition to its clinical applications in treatment of liver diseases, RGSH is also used in the treatment of numerous other diseases, such as malignant tumors and nerve, urological and digestion diseases. However, there are few reports of RGSH being used in treatment of acute kidney injury (AKI), and the mechanism of its action in AKI is not clear. To assess the possible mechanism of RGSH inhibition in AKI, a mouse AKI model and HK‑2 cell ferroptosis model were built to perform in vitro and in vivo experiments. The levels of blood urea nitrogen (BUN) and malondialdehyde (MDA) before and after the RGSH treatment were assessed, and the pathological changes of the kidneys were assessed using hematoxylin and eosin staining. Immunohistochemical (IHC) methods were used to evaluate the expressions of acyl‑CoA synthetase long‑chain family member 4 (ACSL4) and glutathione peroxidase (GPX4) in the kidney tissues, reverse transcription‑quantitative PCR and western blotting were used to assess the levels of ferroptosis marker factors in the kidney tissues and HK‑2 cells, and flow cytometry was used to assess cell death. The results indicated that, RGSH intervention reduced the BUN and serum MDA levels, and ameliorated glomerular damage and the level of renal structure damage in the mouse model. IHC results demonstrated that RGSH intervention could significantly reduce the ACSL4 mRNA expression level and inhibit iron accumulation, and significantly upregulate the GPX4 mRNA expression level. Moreover, RGSH could inhibit ferroptosis induced by ferroptosis inducers erastin and RSL3 in HK‑2 cells. Cell assay results demonstrated that RGSH could improve the lipid oxide level and cell viability, and inhibit cell death, so as to ameliorate the effects of AKI. These results suggested that RGSH could ameliorate AKI by inhibiting ferroptosis, which indicates RGSH as a promising therapeutic strategy for the treatment of AKI.
View Figures

Figure 1

Figure 2

Figure 3

View References

1 

Hounkpatin H, Fraser S, Glidewell L, Blakeman T, Lewington A and Roderick P: Predicting risk of recurrent acute kidney injury: A systematic review. Nephron. 142:83–90. 2019. View Article : Google Scholar : PubMed/NCBI

2 

Saadat-Gilani K and Zarbock A: Perioperative renal protection. Curr Opin Crit Care. 27:676–685. 2021. View Article : Google Scholar : PubMed/NCBI

3 

Calvert S and Shaw A: Perioperative acute kidney injury. Perioper Med (Lond). 1:62012. View Article : Google Scholar : PubMed/NCBI

4 

Singbartl K and Kellum J: AKI in the ICU: Definition, epidemiology, risk stratification, and outcomes. Kidney Int. 81:819–825. 2012. View Article : Google Scholar : PubMed/NCBI

5 

Sul YH, Lee JY, Kim SH, Ye JB, Lee JS, Yoon SY and Choi JH: Risk factors for acute kidney injury in critically ill patients with torso injury: A retrospective observational single-center study. Medicine (Baltimore). 100:e267232021. View Article : Google Scholar : PubMed/NCBI

6 

Dixon S and Stockwell B: The role of iron and reactive oxygen species in cell death. Nat Chem Biol. 10:9–17. 2014. View Article : Google Scholar : PubMed/NCBI

7 

Sha R, Xu Y, Yuan C, Sheng X, Wu Z, Peng J, Wang Y, Lin Y, Zhou L, Xu S, et al: Predictive and prognostic impact of ferroptosis-related genes ACSL4 and GPX4 on breast cancer treated with neoadjuvant chemotherapy. EBioMedicine. 71:1035602021. View Article : Google Scholar : PubMed/NCBI

8 

Carney E: Ferroptotic stress promotes the AKI to CKD transition. Nat Rev Nephrol. 17:6332021. View Article : Google Scholar : PubMed/NCBI

9 

Park EJ, Dusabimana T, Je J, Jeong K, Yun SP, Kim HJ, Kim H and Park SW: Honokiol protects the kidney from renal ischemia and reperfusion injury by upregulating the glutathione biosynthetic enzymes. Biomedicines. 8:3522020. View Article : Google Scholar : PubMed/NCBI

10 

Chen H, Qi Q, Wu N, Wang Y, Feng Q, Jin R and Jiang L: Aspirin promotes RSL3-induced ferroptosis by suppressing mTOR/SREBP-1/SCD1-mediated lipogenesis in PIK3CA-mutatnt colorectal cancer. Redox Biol. 55:1024262022. View Article : Google Scholar : PubMed/NCBI

11 

Xiao MD: J.X: Effect of reduced glutathione on high glucose-induced reactive oxygen species, nuclear factor-kappa B andosteopontin in human renal tubular epithelial cells. Jiangsu Med J. 34:2008.

12 

Leary SLU: W.; Anthony, R.; Cartner, S.; Corey, D.; Grandin, T.; Greenacre, C.; Gwaltney-Bran, S.; McCrackin, M.; Meyer, R.; Miller, D.; Shearer, J.; Yanong, R.; Golab, G.;: Patterson-Kane E AVMA guidelines for the euthanasia of animals: 2013 edition. 2013. https://www.avma.org/KB/Policies/Pages/Euthanasia-Guidelines.aspx

13 

Meng XZ: Ni; Zhang, Min; Song, Xuexia; Liu, Qian; Huang, Xiangyan: Effect of reduced Glutathione onserum and urinary concentration of NGAL in the rodent model of Cisplatin induced acute kidney injur. China J Modern Med. 24:2014.

14 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI

15 

Goren O and Matot I: Perioperative acute kidney injury. Br J Anaesth. 115 (Suppl 2):ii3–ii14. 2015. View Article : Google Scholar : PubMed/NCBI

16 

Kim-Campbell N, Gretchen C, Callaway C, Felmet K, Kochanek PM, Maul T, Wearden P, Sharma M, Viegas M, Munoz R, et al: Cell-free plasma hemoglobin and male gender are risk factors for acute kidney injury in low risk children undergoing cardiopulmonary bypass. Crit Care Med. 45:e1123–e1130. 2017. View Article : Google Scholar : PubMed/NCBI

17 

Liu D, Zhang C, Hu M and Su K: Scutellarein relieves the death and inflammation of tubular epithelial cells in ischemic kidney injury by degradation of COX-2 protein. Int Immunopharmacol. 101:1081932021. View Article : Google Scholar : PubMed/NCBI

18 

Lane D, Metselaar B, Greenough M, Bush A and Ayton S: Ferroptosis and NRF2: An emerging battlefield in the neurodegeneration of Alzheimer's disease. Essays Biochem. 65:925–940. 2021. View Article : Google Scholar : PubMed/NCBI

19 

Xiong R, He R, Liu B, Jiang W, Wang B, Li N and Geng Q: Ferroptosis: A new promising target for lung cancer therapy. Oxid Med Cell Longev. 2021:84575212021. View Article : Google Scholar : PubMed/NCBI

20 

Li C, Sun G, Chen B, Xu L, Ye Y, He J, Bao Z, Zhao P, Miao Z, Zhao L, Hu J, You Y, Liu N, Chao H and Ji J: Nuclear receptor coactivator 4-mediated ferritinophagy contributes to cerebral ischemia-induced ferroptosis in ischemic stroke. Pharmacol Res. 174:1059332021. View Article : Google Scholar : PubMed/NCBI

21 

Bao Z, Liu Y, Chen B, Miao Z, Tu Y, Li C, Chao H, Ye Y, Xu X, Sun G, et al: Prokineticin-2 prevents neuronal cell deaths in a model of traumatic brain injury. Nat Commun. 12:42202021. View Article : Google Scholar : PubMed/NCBI

22 

Wang J, Liu Y, Wang Y and Sun L: The cross-link between ferroptosis and kidney diseases. Oxid Med Cell Longev. 2021:66548872021.PubMed/NCBI

23 

Wang Y, Quan F, Cao Q, Lin Y, Yue C, Bi R, Cui X, Yang H, Yang Y, Birnbaumer L, et al: Quercetin alleviates acute kidney injury by inhibiting ferroptosis. J Adv Res. 28:231–243. 2021. View Article : Google Scholar : PubMed/NCBI

24 

Martines A, Masereeuw R, Tjalsma H, Hoenderop J, Wetzels J and Swinkels D: Iron metabolism in the pathogenesis of iron-induced kidney injury. Nat Rev Nephrol. 9:385–398. 2013. View Article : Google Scholar : PubMed/NCBI

25 

Zhao Z, Wu J, Xu H, Zhou C, Han B, Zhu H, Hu Z, Ma Z, Ming Z, Yao Y, et al: XJB-5-131 inhibited ferroptosis in tubular epithelial cells after ischemia-reperfusion injury. Cell Death Dis. 11:6292020. View Article : Google Scholar : PubMed/NCBI

26 

Chen C, Wang D, Yu Y, Zhao T, Min N, Wu Y, Kang L, Zhao Y, Du L, Zhang M, et al: Legumain promotes tubular ferroptosis by facilitating chaperone-mediated autophagy of GPX4 in AKI. Cell Death Dis. 12:652021. View Article : Google Scholar : PubMed/NCBI

27 

Vairetti M, Di Pasqua L, Cagna M, Richelmi P, Ferrigno A and Berardo C: Changes in glutathione content in liver diseases: An update. Antioxidants (Basel). 10:3642021. View Article : Google Scholar : PubMed/NCBI

28 

Santos NA, Bezerra CS, Martins NM, Curti C, Bianchi ML and Santos AC: Hydroxyl radical scavenger ameliorates cisplatin-induced nephrotoxicity by preventing oxidative stress, redox state unbalance, impairment of energetic metabolism and apoptosis in rat kidney mitochondria. Cancer Chemother Pharmacol. 61:145–155. 2008. View Article : Google Scholar : PubMed/NCBI

29 

Han P, Qin Z, Tang J, Xu Z, Li R, Jiang X, Yang C, Xing Q, Qi X, Tang M, et al: RTA-408 protects kidney from ischemia-reperfusion injury in mice via activating Nrf2 and downstream GSH biosynthesis gene. Oxid Med Cell Longev. 2017:76121822017. View Article : Google Scholar : PubMed/NCBI

30 

Jia D, Zheng J, Zhou Y, Jia J, Ye X, Zhou B, Chen X, Mo Y and Wang J: Ferroptosis is involved in hyperoxic lung injury in neonatal rats. J Inflamm Res. 14:5393–5401. 2021. View Article : Google Scholar : PubMed/NCBI

31 

Zuk A and Bonventre JV: Acute kidney injury. Annu Rev Med. 67:293–307. 2016. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
He L and Shi Y: Reduced glutathione ameliorates acute kidney injury by inhibiting ferroptosis. Mol Med Rep 27: 123, 2023.
APA
He, L., & Shi, Y. (2023). Reduced glutathione ameliorates acute kidney injury by inhibiting ferroptosis. Molecular Medicine Reports, 27, 123. https://doi.org/10.3892/mmr.2023.13011
MLA
He, L., Shi, Y."Reduced glutathione ameliorates acute kidney injury by inhibiting ferroptosis". Molecular Medicine Reports 27.6 (2023): 123.
Chicago
He, L., Shi, Y."Reduced glutathione ameliorates acute kidney injury by inhibiting ferroptosis". Molecular Medicine Reports 27, no. 6 (2023): 123. https://doi.org/10.3892/mmr.2023.13011
Copy and paste a formatted citation
x
Spandidos Publications style
He L and Shi Y: Reduced glutathione ameliorates acute kidney injury by inhibiting ferroptosis. Mol Med Rep 27: 123, 2023.
APA
He, L., & Shi, Y. (2023). Reduced glutathione ameliorates acute kidney injury by inhibiting ferroptosis. Molecular Medicine Reports, 27, 123. https://doi.org/10.3892/mmr.2023.13011
MLA
He, L., Shi, Y."Reduced glutathione ameliorates acute kidney injury by inhibiting ferroptosis". Molecular Medicine Reports 27.6 (2023): 123.
Chicago
He, L., Shi, Y."Reduced glutathione ameliorates acute kidney injury by inhibiting ferroptosis". Molecular Medicine Reports 27, no. 6 (2023): 123. https://doi.org/10.3892/mmr.2023.13011
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team